Teyi Pharmaceutical Group Co.,Ltd (SHE:002728)

SHE:002728 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Jan 1, 2022
Cash & Equivalents	140.33	126.15	457.41	647.25	739.66	372.47
Trading Asset Securities	225	210	-	-	-	-
Cash & Short-Term Investments	365.33	336.15	457.41	647.25	739.66	372.47
Cash Growth	30.40%	-26.51%	-29.33%	-12.49%	98.58%	-35.24%
Accounts Receivable	234.39	253.59	205.32	156	133.02	126.66
Other Receivables	0.81	0.8	9.38	13.94	16.87	1.36
Receivables	235.2	254.39	214.7	169.94	149.9	128.02
Inventory	256.91	237.63	264.38	271.83	208.23	195.31
Prepaid Expenses	-	-	-	-	-	0.69
Other Current Assets	34.41	29.43	14.46	16.13	31.08	15.45
Total Current Assets	891.85	857.6	950.95	1,105	1,129	711.95
Property, Plant & Equipment	721.94	733.31	721.4	656.49	648.01	601.68
Long-Term Investments	13.5	13.5	13.5	13.5	13.5	-
Goodwill	517.6	517.6	517.6	529.23	542.4	542.4
Other Intangible Assets	137.72	141.22	138.63	151.24	153.87	156.75
Long-Term Deferred Tax Assets	21.33	28.43	21.85	18.4	18.81	17.18
Long-Term Deferred Charges	9.02	7.29	17.41	13.45	11.48	15.6
Other Long-Term Assets	15.14	12.47	19.54	25.18	28.67	20.65
Total Assets	2,328	2,311	2,401	2,513	2,546	2,066

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Jan 1, 2022
Accounts Payable	69.63	68.63	44.83	83	76.29	52.35
Accrued Expenses	7.91	40.62	19.37	32.5	30.42	20.09
Short-Term Debt	288.58	263.54	516.09	306	633.68	377
Current Portion of Long-Term Debt	-	-	-	-	213.5	-
Current Income Taxes Payable	7.02	3.92	0.72	13.65	4.86	8.59
Current Unearned Revenue	43.61	62.18	11.05	24.26	130.69	31.06
Other Current Liabilities	26.88	15.45	3.96	6.36	19.81	7.25
Total Current Liabilities	443.63	454.33	596.02	465.77	1,109	496.34
Long-Term Debt	-	-	-	-	-	285.18
Long-Term Unearned Revenue	18.88	17.27	20.57	20.77	18.51	11.72
Long-Term Deferred Tax Liabilities	18.3	18.36	19.36	15.42	14.71	11.27
Total Liabilities	480.81	489.96	635.94	501.95	1,142	804.51

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Jan 1, 2022
Common Stock	513.31	513.31	512.21	364.69	229.18	221.64
Additional Paid-In Capital	849.97	849.97	844.13	982	575.92	460.91
Retained Earnings	578.29	552.53	495.8	657.68	553.51	519.38
Treasury Stock	-101.19	-101.19	-93.86	-	-	-
Comprehensive Income & Other	6.91	6.85	6.65	6.31	44.53	59.75
Shareholders' Equity	1,847	1,821	1,765	2,011	1,403	1,262
Total Liabilities & Equity	2,328	2,311	2,401	2,513	2,546	2,066

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Jan 1, 2022
Total Debt	288.58	263.54	516.09	306	847.18	662.18
Net Cash (Debt)	76.75	72.61	-58.68	341.25	-107.52	-289.71
Net Cash Growth	280.70%	-	-	-	-	-
Net Cash Per Share	0.15	0.14	-0.11	0.74	-0.25	-0.72
Filing Date Shares Outstanding	499.58	499.58	500.58	510.56	449.27	434.42
Total Common Shares Outstanding	499.58	499.58	499.49	510.56	449.19	434.42
Working Capital	448.23	403.27	354.93	639.39	19.62	215.61
Book Value Per Share	3.70	3.65	3.53	3.94	3.12	2.90
Tangible Book Value	1,192	1,163	1,109	1,330	706.87	562.55
Tangible Book Value Per Share	2.39	2.33	2.22	2.61	1.57	1.29
Buildings	-	608.2	527.78	542.22	412.29	419.33
Machinery	-	439.2	418.7	329.97	259.01	254.01
Construction In Progress	-	118.38	157.88	131.95	280.88	198.46

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 20, 2026

Data Sources Report a data error